694
Views
88
CrossRef citations to date
0
Altmetric
Original

Improving locoregional hyperthermia delivery using the 3-D controlled AMC-8 phased array hyperthermia system: A preclinical study

, , , , , , , , , , & show all
Pages 581-592 | Received 09 Apr 2009, Accepted 26 Jul 2009, Published online: 24 Oct 2009

References

  • Field SB. In vivo aspects of hyperthermic oncology. An introduction to the practical aspects of clinical hyperthermia, SB Field, J Hand. Taylor and Francis, London 1990; 55–68
  • Raaphorst G. Fundamental aspects of hyperthermic biology. An introduction to the practical aspects of clinical hyperthermia, SB Field, J Hand. Taylor and Francis, London 1990; 10–54
  • Overgaard J, Radacic MM, Grau C. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo. Cancer Res 1991; 51: 707–711
  • Sminia P, Los G, Hendriks JJ, van Vugt MJ, Haveman J, Gonzalez GD. The influence of hyperthermia on the uptake of cisplatin in the rat cervical spinal cord. Eur J Cancer 1992; 28A: 1139–1143
  • Dahl O. Interaction of heat and drugs in vitro and in vivo 1995; 103–121
  • Hettinga JV, Konings AW, Kampinga HH. Reduction of cellular cisplatin resistance by hyperthermia–A review. Int J Hyperthermia 1997; 13: 439–457
  • Rietbroek RC, van de Vaart PJ, Haveman J, Blommaert FA, Geerdink A, Bakker PJ, Veenhof CH. Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells. J Cancer Res Clin Oncol 1997; 123: 6–12
  • Westermann AM, Jones EL, Schem B-C, van der Steen-Banasik EM, Koper P, Mella O, Uitterhoeve AL, de Wit R, van der Velden J, Burger C, et al. First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma. Cancer 2005; 104: 763–770
  • Romano M, Maluta S, Cordiano C, Delaini GG, Genna M, Oliani C, Capelli P, Tomezzolli A, Manfrini C, Porcaro AB, et al. Pre-operative radio-chemotherapy plus regional hyperthermia in the treatment of advanced rectal cancer: Experience with radiation dose escalation. Int J Radiat Oncol Biol Phys 2003; 57: S386–S387
  • Datta NR, Bose AK, Kapoor HK, Gupta S. Head and neck cancers: Results of thermoradiotherapy versus radiotherapy. Int J Hyperthermia 1990; 6: 479–486
  • Overgaard J, Gonzalez GD, Hulshof MC, Arcangeli G, Dahl O, Mella O, Bentzen SM. European Society for Hyperthermic Oncology. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 1995; 345: 540–543
  • Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, van Putten WL, van Rhoon GC, van Dijk JD, González GD, et al. International Collaborative Hyperthermia Group. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials. Int J Radiat Oncol Biol Phys 1996; 35: 731–744
  • Rau B, Wust P, Hohenberger P, Loffel J, Hunerbein M, Below C, Gellermann J, Speidel A, Vogl T, Riess H, et al. Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: A phase II clinical trial. Ann Surg 1998; 227: 380–389
  • van der Zee J, Gonzalez GD, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Dutch Deep Hyperthermia Group. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Lancet 2000; 355: 1119–1125
  • van der Zee J, Gonzalez GD. The Dutch Deep Hyperthermia Trial: Results in cervical cancer. Int J Hyperthermia 2002; 18: 1–12
  • Field SB, Morris CC. The relationship between heating time and temperature: Its relevance to clinical hyperthermia. Radiother Oncol 1983; 1: 179–186
  • Dewhirst MW, Sim DA, Sapareto S, Connor WG. Importance of minimum tumor temperature in determining early and long-term responses of spontaneous canine and feline tumors to heat and radiation. Cancer Res 1984; 44: 43–50
  • Shimm DS, Kittelson JM, Oleson JR, Aristizabal SA, Barlow LC, Cetas TC. Interstitial thermoradiotherapy: Thermal dosimetry and clinical results. Int J Radiat Oncol Biol Phys 1990; 18: 383–387
  • Cox RS, Kapp DS. Correlation of thermal parameters with outcome in combined radiation therapy-hyperthermia trials. Int J Hyperthermia 1992; 8: 719–732
  • Sneed PK, Gutin PH, Stauffer PR, Phillips TL, Prados MD, Weaver KA, Suen S, Lamb SA, Ham B, Ahn DK, et al. Thermoradiotherapy of recurrent malignant brain tumors. Int J Radiat Oncol Biol Phys 1992; 23: 853–861
  • Oleson JR, Samulski TV, Leopold KA, Clegg ST, Dewhirst MW, Dodge RK, George SL. Sensitivity of hyperthermia trial outcomes to temperature and time: Implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys 1993; 25: 289–297
  • Kapp DS, Cox RS. Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast. Int J Radiat Oncol Biol Phys 1995; 33: 887–899
  • Sherar M, Liu FF, Pintilie M, Levin W, Hunt J, Hill R, Hand J, Vernon C, van Rhoon G, van der Zee J, et al. Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: Data from a phase III trial. Int J Radiat Oncol Biol Phys 1997; 39: 371–380
  • Wust P, Rau B, Gellerman J, Pegios W, Loffel J, Riess H, et al. Radiochemotherapy and hyperthermia in the treatment of rectal cancer. Recent Results Cancer Res 1998; 146: 175–191
  • Dewhirst M. Thermal dosimetry. Thermo-radiotherapy and thermochemotherapy, MH Seegenschmiedt, P Fessenden, C Vernon. Springer, Berlin 1995; 123–136
  • Leopold KA, Dewhirst MW, Samulski TV, Dodge RK, George SL, Blivin JL, Prosnitz LR, Oleson JR. Cumulative minutes with T90 greater than Tempindex is predictive of response of superficial malignancies to hyperthermia and radiation. Int J Radiat Oncol Biol Phys 1993; 25: 841–847
  • Overgaard J, Gonzalez GD, Hulshof MC, Arcangeli G, Dahl O, Mella O, Bentzen SM. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia 1996; 12: 3–20
  • Myerson RJ, Perez CA, Emami B, Straube W, Kuske RR, Leybovich L, Von Gerichten D. Tumor control in long-term survivors following superficial hyperthermia. Int J Radiat Oncol Biol Phys 1990; 18: 1123–1129
  • Thrall DE, LaRue SM, Yu D, Samulski T, Sanders L, Case B, Rosner G, Azuma C, Poulson J, Pruitt AF, et al. Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy. Clin Cancer Res 2005; 11: 5206–5214
  • Maguire PD, Samulski TV, Prosnitz LR, Jones EL, Rosner GL, Powers B, Layfield LW, Brizel DM, Scully SP, Harrelson JM, et al. A phase II trial testing the thermal dose parameter CEM43° T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy. Int J Hyperthermia 2001; 17: 283–290
  • Hand JW, Machin D, Vernon CC, Whaley JB. Analysis of thermal parameters obtained during phase III trials of hyperthermia as an adjunct to radiotherapy in the treatment of breast carcinoma. Int J Hyperthermia 1997; 13: 343–364
  • Seegenschmiedt MH, Martus P, Fietkau R, Iro H, Brady LW, Sauer R. Multivariate analysis of prognostic parameters using interstitial thermoradiotherapy (IHT-IRT): Tumor and treatment variables predict outcome. Int J Radiat Oncol Biol Phys 1994; 29: 1049–1063
  • Prionas SD, Kapp DS, Goffinet DR, Ben-Yosef R, Fessenden P, Bagshaw MA. Thermometry of interstitial hyperthermia given as an adjuvant to brachytherapy for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1994; 28: 151–162
  • Wust P, Stahl H, Loffel J, Seebass M, Riess H, Felix R. Clinical, physiological and anatomical determinants for radiofrequency hyperthermia. Int J Hyperthermia 1995; 11: 151–167
  • Ryan TP, Trembly BS, Roberts DW, Strohbehn JW, Coughlin CT, Hoopes PJ. Brain hyperthermia: I. Interstitial microwave antenna array techniques–The Dartmouth experience. Int J Radiat Oncol Biol Phys 1994; 29: 1065–1078
  • Kroeze H, van de Kamer JB, de Leeuw AA, Lagendijk JJ. Regional hyperthermia applicator design using FDTD modelling. Phys Med Biol 2001; 46: 1919–1935
  • Wust P, Beck R, Berger J, Fahling H, Seebass M, Wlodarczyk W, Hoffmann W, Nadobny J. Electric field distributions in a phased-array applicator with 12 channels: Measurements and numerical simulations. Med Phys 2000; 27: 2565–2579
  • Nadobny J, Fahling H, Hagmann MJ, Turner PF, Wlodarczyk W, Gellermann JM, Deuflhard P, Wust P. Experimental and numerical investigation of feed-point parameters in a 3-D hyperthermia applicator using different FDTD models of feed networks. IEEE Trans Biomed Eng 2002; 49: 1348–1359
  • van Dijk J, Gonzalez DG, Blank LE. Deep local hyperthermia with a four aperture array system of large waveguide applicators. Results of simulations and clinical application. Hyperthermic Oncology. Taylor and Francis, London 1988; 573–575
  • van Dijk JD, Schneider C, van Os R, Blank LE, Gonzalez DG. Results of deep body hyperthermia with large waveguide radiators. Adv Exp Med Biol 1990; 267: 315–319
  • Schneider C, van Dijk JD. Visualization by a matrix of light-emitting diodes of interference effects from a radiative four-applicator hyperthermia system. Int J Hyperthermia 1991; 7: 355–366
  • Schneider CJ, de Leeuw AA, van Dijk JD. Quantitative determination of SAR profiles from photographs of the light-emitting diode matrix. Int J Hyperthermia 1992; 8: 609–619
  • Schneider CJ, van Dijk JD, de Leeuw AA, Wust P, Baumhoer W. Quality assurance in various radiative hyperthermia systems applying a phantom with LED matrix. Int J Hyperthermia 1994; 10: 733–747
  • Schneider CJ, Kuijer JP, Colussi LC, Schepp CJ, van Dijk JD. Performance evaluation of annular arrays in practice: The measurement of phase and amplitude patterns of radio-frequency deep body applicators. Med Phys 1995; 22: 755–765
  • Crezee J, Kok HP, Wiersma J, van Stam G, Sijbrands J, Bel A, van Haaren PM. Improving locoregional hyperthermia equipment using 3-D power control: From AMC-4 to AMC-8. Proceedings 22nd annual meeting of the European Society for Hyperthermic Oncology (Graz) 2005. pp 14–15
  • Wiersma J. Pre-implementation simulations to improve the axial control of a waveguide based hyperthermia system. Hyperthermia treatment planning for the AMC-4 system using the WF-CGFFT method. PhD thesis. 2005. pp 111–122
  • Van de Kamer JB, De Leeuw AA, Hornsleth SN, Kroeze H, Kotte AN, Lagendijk JJ. Development of a regional hyperthermia treatment planning system. Int J Hyperthermia 2001; 17: 207–220
  • van de Kamer JB, van Vulpen M, de Leeuw AA, Kroeze H, Lagendijk JJ. CT-resolution regional hyperthermia treatment planning. Int J Hyperthermia 2002; 18: 104–116
  • Kok HP, Van Haaren PM, Van de Kamer JB, Wiersma J, van Dijk JD, Crezee J. High resolution temperature based optimisation for hyperthermia treatment planning. Phys Med Biol 2005; 50: 3127–3141
  • Hagmann MJ, Levin RL, Turner PF. A comparison of the annular phased array to helical coil applicators for limb and torso hyperthermia. IEEE Trans Biomed Eng 1985; 32: 916–926
  • van Stam G, Wiersma J, van Wieringen N, van Dijk J. Performance tests of an electric field measurement system. Proceedings 18th Annual meeting of the European Society for Hyperthermic Oncology; 1999. p 80
  • de Leeuw AA, Crezee J, Lagendijk JJ. Temperature and SAR measurements in deep-body hyperthermia with thermocouple thermometry. Int J Hyperthermia 1993; 9: 685–697
  • Wiersma J, van Wieringen N, Crezee H, van Dijk JD. Delineation of potential hot spots for hyperthermia treatment planning optimisation. Int J Hyperthermia 2007; 23: 287–301
  • Wust P, Seebass M, Nadobny J, Deuflhard P, Monich G, Felix R. Simulation studies promote technological development of radiofrequency phased array hyperthermia. Int J Hyperthermia 1996; 12: 477–494
  • Seebass M, Beck R, Gellermann J, Nadobny J, Wust P. Electromagnetic phased arrays for regional hyperthermia: Optimal frequency and antenna arrangement. Int J Hyperthermia 2001; 17: 321–336
  • Paulsen KD, Geimer S, Tang J, Boyse WE. Optimization of pelvic heating rate distributions with electromagnetic phased arrays. Int J Hyperthermia 1999; 15: 157–186
  • Wiersma J, van Maarseveen RA, van Dijk JD. A flexible optimization tool for hyperthermia treatments with RF phased array systems. Int J Hyperthermia 2002; 18: 73–85
  • Cheng KS, Stakhursky VL, Stauffer P, Dewhirst M, Das SK. Online feedback focusing algorithm for hyperthermia cancer treatment. Int J Hyperthermia 2007; 23: 539–554
  • Weihrauch M, Wust P, Weiser M, Nadobny J, Eisenhardt S, Budach V, Gellermann J. Adaptation of antenna profiles for control of MR guided hyperthermia (HT) in a hybrid MR-HT system. Med Phys 2007; 34: 4717–4725
  • Cheng KS, Yuan Y, Li Z, Stauffer PR, Maccarini P, Joines WT, Dewhirst MW, Das SK. The performance of a reduced-order adaptive controller when used in multi-antenna hyperthermia treatments with nonlinear temperature-dependent perfusion. Phys Med Biol 2009; 54: 1979–1995
  • Stakhursky VL, Arabe O, Cheng KS, Macfall J, Maccarini P, Craciunescu O, Dewhirst M, Stauffer P, Das SK. Real-time MRI-guided hyperthermia treatment using a fast adaptive algorithm. Phys Med Biol 2009; 54: 2131–2145

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.